Cedecea lapagei pneumonia: the first reported case in Italy and literature review
Abstract
Cedecea lapagei is a rare Gram-negative bacillus of the Enterobacteriaceae family, typically identified as an opportunistic pathogen in immunocompromised or critically ill patients. Less than twenty clinically significant infections have been described worldwide, many displaying concerning multidrug-resistance profiles. We report the first documented case of C. lapagei pneumonia in Italy, occurring in a 73-year-old man with hypogammaglobulinemia and post-stroke dysphagia who presented with a recurrence of pneumonia. Bronchoalveolar Lavage Fluid (BALF) obtained for diagnostic clarification yielded C. lapagei as the causative organism. A literature review on C. lapagei pneumonia has been conducted as well. This case underscores the pathogenic potential of C. lapagei in vulnerable hosts and highlights the importance of thorough microbiological investigation and targeted antimicrobial therapy, given its unpredictable and often extensive antimicrobial resistance pattern.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.